RTSIG

Meagan de la Bastide discussed robust optimisation in lung sabr #ROBRT2022

Maan Najem gave a very practical and interesting talk on the plan complexity levers in eclipse #ROBRT2022

Virginia Anaya talks on the deformable registration capabilities of Velocity for head and neck treatment planning #ROBRT2022

Michael Lam put some detail on plan robustness to setup error in stereotactic radiosurgery #ROBRT2022

Andrew Bird talking on the subject of robust planning for IMC plans at #ROBRT2022

Great talk from Frank Brewster on early bladder experience with the MR linac #ROBRT2022

David Buckle discussed an audit of adaptive practice #ROBRT2022

Hannah Chantler talking about getting the right dose in the right place at the right time. One of two invited speakers at #ROBRT2022

Mark Cowen kicking #ROBRT2022 off with some very interesting house keeping rules 😜

Nearly ready to go for #ROBRT2022! Venue looks good, nicely air conditioned, essential on a day like this 🥵

Here's a radiotherapy robustness tree to keep you going until then

We're excited for #ROBRT2022 on Thursday and there's still time to book on! Ends midday Monday the 13th. ipem.ac.uk/what-s-on/ipem…

Did you make it #MRRT2022? We had a great time in Manchester yesterday hearing from a range of contributors on advances in MRI for radiotherapy. Don't feel left out though... Come along to #ROBRT2022 in London on June 16th when we'll be looking at plan robustness for RT.

Emma Doran evaluated different couch top configurations for an MR sim at the Beatson Cancer Centre in Glasgow #MRRT2022

David Bird talking about MR only planning studies from Leeds #MRRT2022

JJ returned for a second talk to describe a method for tracking organ motion in the pelvis based on bladder filling. #MRRT2022

Alex Dunlop provided an overview of experiences with the MR linac at the Royal Marsden. #MRRT2022

Christopher Moore explained a study which looked at adc values measured on the #unity linac for prostate patients over the course of treatment. No significant differences were seen in long course treatments or sabr #MRRT2022

Dr Petra van Houdt explained the imaging biomarker studies being done at the Netherlands Cancer Institute. She presented the talk remotely and answered questions over teams.